AI_PREMie
The AI PREMie team, led by Professor Patricia Maguire from UCD School of Biomolecular and Biomedical Science, has been awarded €500,000 in recognition of the potential impact of their AI-powered risk stratification platform for preeclampsia. Also from the UCD ConwaySPHERE research group, the team includes Consultant Obstetrician and Gynaecologist Professor Mary Higgins and Consultant Haematologist and Full Clinical Professor Fionnuala Ní Áinle, UCD School of Medicine, and Dr Paulina Szklanna, UCD School of Biomolecular and Biomedical Science.
Preeclampsia (PET) is a condition of pregnancy that is difficult to diagnose and kills 50,000 mothers and 500,000 babies globally every year. At present delivery of the pre-term baby is the only treatment and the safest option for the mother. But pre-term delivery can lead to long-term neurodevelopmental problems and even death. ConwaySPHERE is working to develop a new diagnostic test called AI PREMie to better predict PET severity and help save the lives of both mothers and their babies. It is a risk stratification tool that identifies women with PET - and also how the condition will progress. Our AI PREMie tool assesses the pre-eclampsia risk based on circulating biomarkers in the plasma of pregnant mothers. This will give clinicians and other caregivers the opportunity to proactively plan pregnancies for at-risk mothers, giving a clearer understanding if planning for delivery is necessary or if the baby can stay in utero allowing for further development as every day in utero counts.
AI_PREMie Timeline
2017
Elevated plasma TFPI activity causes attenuated TF-dependent thrombin generation in early-onset preeclampsia.
Early onset preeclampsia (EOP) is a pregnancy-specific proinflammatory disorder that is characterised by competing thrombotic and bleeding risks. It was the aim of this study to characterise thrombin generation, a major determinant of thrombotic and bleeding risk, in order to better understand the haemostatic balance in patients with EOP.
Read More
2018
CAPE Study Results
Retrospective secondary analysis of an observational study in an Irish tertiary referral centre with 9000 deliveries annually. The MPV of 27 women with EOPE was compared to 19 unaffected controls. The inclusion criteria for the disease state was the development of EOPE defined by the National Institute for Health and Care Excellence (NICE) guideline, as new onset hypertension presenting after 20 weeks and prior to 34 weeks with significant proteinuria.
Read More
Platelet Releasate Proteome Profiling Reveals a Core Set of Proteins with Low Variance between Healthy Adults.
Upon activation, platelets release a powerful cocktail of soluble and vesicular signals, collectively termed the "platelet releasate" (PR). Although several studies have used qualitative/quantitative proteomic approaches to characterize PR; with debated content and significant inter-individual variability reported, confident, and reliable insights have been hindered. Using label-free quantitative (LFQ)-proteomics analysis, a reproducible, quantifiable investigation of the 1U mL−1 thrombin-induced PR from 32 healthy adults was conducted.
Read More
The Hundred-Person Platelet Releasate Project.
Upon activation platelets release a host of soluble and vesicular signals, collectively termed the ‘platelet releasate’ (PR). The contents of this PR play a significant role in haemostasis, wound healing, tissue regeneration, inflammation, and pathologic sequelae.
Read More
2019
Science Foundation Ireland Future Innovator Prize
AI for Societal Good Challenge
Supports interdisciplinary teams to develop novel, potentially disruptive AI-based solutions that address significant national and global societal challenges
Read More
The platelet releasate in pregnancy and early-onset preeclampsia.
Read More
2020
Irish Tech news article
Article in Roller coaster
SAS Viya join the AI-PREMie team
2021
Winner of the NovaUCD Innovation of the Year Award 2021
Siliconrepublic article
Runner up SFI Future Innovator Artificial Intelligence (AI) for Societal Goo
Finalist of Analytics Institute Social Impact Award.
"Using platelets as little health sensors in our blood" - The Irish Times
"Using platelets as little health sensors in our blood" - Recruitment for Technology
Engineers Ireland Article
the pan Canadian thrombotic Research Network
the iPlacenta H2020 virtual conference
Teck Expert Article
Geant Article
HEAnet Article
Science Direct Article
University Observer Interview
AI_PREMie in 2021 AI_Awards Finalists
International Society on Thrombosis and Haemostasis Poster
Research Impact Case Study Competition - runner up
AI_PREMie featured in RTE One in the "Science to the Rescue" show.
AI_PREMie project features in final #TheHealthPulse podcast of 2021 by @SASsoftware
Professor Maguire discusses AI_PREMie on #Allreland podcast
Article by Leaps
Article by Medicalxpress
2022
Professor Patricia Maguire interviewed on Newstalk The Pat Kenny Show discussing AI_PREMie project
AI_PREMie featured in RTE Changemakers
Microsoft recently published an article about AI_PREMie
Read more here:
AI_PREMie
The AI PREMie team, led by Professor Patricia Maguire from UCD School of Biomolecular and Biomedical Science, has been awarded €500,000 in recognition of the potential impact of their AI-powered risk stratification platform for preeclampsia. Also from the UCD ConwaySPHERE research group, the team includes Consultant Obstetrician and Gynaecologist Professor Mary Higgins and Consultant Haematologist and Full Clinical Professor Fionnuala Ní Áinle, UCD School of Medicine, and Dr Paulina Szklanna, UCD School of Biomolecular and Biomedical Science.
Preeclampsia (PET) is a condition of pregnancy that is difficult to diagnose and kills 50,000 mothers and 500,000 babies globally every year. At present delivery of the pre-term baby is the only treatment and the safest option for the mother. But pre-term delivery can lead to long-term neurodevelopmental problems and even death. ConwaySPHERE is working to develop a new diagnostic test called AI PREMie to better predict PET severity and help save the lives of both mothers and their babies. It is a risk stratification tool that identifies women with PET - and also how the condition will progress. Our AI PREMie tool assesses the pre-eclampsia risk based on circulating biomarkers in the plasma of pregnant mothers. This will give clinicians and other caregivers the opportunity to proactively plan pregnancies for at-risk mothers, giving a clearer understanding if planning for delivery is necessary or if the baby can stay in utero allowing for further development as every day in utero counts.
AI_PREMie Timeline
2017
Elevated plasma TFPI activity causes attenuated TF-dependent thrombin generation in early-onset preeclampsia.
2018
CAPE Study Results
Platelet Releasate Proteome Profiling Reveals a Core Set of Proteins with Low Variance between Healthy Adults.
The Hundred-Person Platelet Releasate Project.
2019
Science Foundation Ireland Future Innovator Prize
The platelet releasate in pregnancy and early-onset preeclampsia.
2020
Irish Tech news article
Article in Roller coaster
SAS Viya join the AI-PREMie team
2021
Winner of the NovaUCD Innovation of the Year Award 2021
Siliconrepublic article
Runner up SFI Future Innovator Artificial Intelligence (AI) for Societal Goo
Finalist of Analytics Institute Social Impact Award.
"Using platelets as little health sensors in our blood" - The Irish Times
"Using platelets as little health sensors in our blood" - Recruitment for Technology
Engineers Ireland Article
the pan Canadian thrombotic Research Network
the iPlacenta H2020 virtual conference
Teck Expert Article
Geant Article
HEAnet Article
Science Direct Article
University Observer Interview
AI_PREMie in 2021 AI_Awards Finalists
International Society on Thrombosis and Haemostasis Poster
Research Impact Case Study Competition - runner up
AI_PREMie featured in RTE One in the "Science to the Rescue" show.
AI_PREMie project features in final #TheHealthPulse podcast of 2021 by @SASsoftware
Professor Maguire discusses AI_PREMie on #Allreland podcast
Article by Leaps
Article by Medicalxpress
2022
Professor Patricia Maguire interviewed on Newstalk The Pat Kenny Show discussing AI_PREMie project
AI_PREMie featured in RTE Changemakers
Microsoft recently published an article about AI_PREMie
Read more here: